Preparation method of pai-cpt reduction-responsive dual-drug delivery nanoparticles
A nano-particle and double-drug technology, which is applied in the direction of pharmaceutical formulas, medical preparations with non-active ingredients, medical preparations containing active ingredients, etc., can solve the problems of unguaranteed therapeutic effect, cumbersome multi-step synthesis and purification, etc., to achieve The effect of improving efficiency
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0047] Synthesis of DSSP-OH: 2,2'-dipyridine disulfide (5.6 g, 25.5 mmol) was dissolved in 30 mL of methanol, and 0.5 ml of glacial acetic acid was added as a catalyst, and thiol ethanol was slowly added to 20 minutes (1.34 g, 17.1 mmol) The dilution in 10 ml of methanol was stirred at room temperature for 3 hours. After the reaction, the mixture was dried in vacuo to the yellow oil, ethyl acetate: hexane = 3: 7 (v / v) Elite, purified crude product by silica gel chromatography, yield: 54.8%, 1 HNMR (400 MHz, chloroform-D) δ 8.52 (DDD, 1H), 7.61 (m, 1H), 7.40 (DT, 1H), 7.15 (M, 1H), 5.77 (T, 1H), 3.83 (M, 2H) ), 2.95 (m, 2h);
[0048] Synthesis of CPT-DSSP: CPT (2.0 g, 5.74 mmol), 4-dimethylaminopyridine (DMAP, 2.10 g, 17.2 mmol) and Trinity (0.567 g, 1.92 mmol) were suspended at 50 ml of anhydrous dichloromethane The mixture was stirred under argon at room temperature, and then the DSSP-OH (1.18 g, 6.31 mmol) solution dissolved in anhydrous THF was added to the mixture, and the r...
Embodiment 2
[0056] In vitro drug release: Reduction of P1-P3 PDNPS by dialysis method - Response type drug release. Typically, a 1 mL P1-P3 PDNPS reserve solution was added to the dialysis tube (MWCO: 3500da), and PBS (10 mM) was dialyzed at 37 ° C. Different concentrations of GSH (2 μm, 5 mm, and 10 mm) were used in dialysis for each PDNPS. The aliquot of the solution was collected by the different time points and the same volume of PBS is collected. Based on fluorescence spectrophotometer (E x = 370 nm, e m = 435 nm) Draw standard curve calculated the amount of CPT released. In addition to DOX fluorescence detection wavelength, E x = 488nm, e m = 591 nm, the in vitro drug release of dual-load P1-P3 PDNPs was determined by the same method.
[0057] Cell culture: from the cytoplasma of Shanghai Cell Biology Research Institute (4T1 cells), cervical cancer cells (HELA cells) and human fibrous sarcoma cells (HT-1080 cells). The cells were raised in Eagle medium (DMEM) or Roswell ParkMemorial Ins...
Embodiment 3
[0062] Example 1 and Example 2 experimental results:
[0063] Synthesis and Characterization of PAI-CPT Prodrugs: This study adopts previous research methods, with sulfide maleimide monomers and 4,7,10-trioxidant-1, 13-detexadylene (diamine) 220) Equation Molar ratio polycondensation of aliphatic PAI (polyamide-imide), synthetic route figure 2 . The quantitative feature of thiorectyl and amine-maleimide Michael addex is very efficiently synthesized and promotes the original one-pot modification of PAIS. Prior to PAI-CPT coupling, the total yield of about 33% by two-step synthesis of pyridine disulfide modified CPT (ie, CPT-DSSP) drug precursors. 1 H and 13 C Magnetic resonance results confirm its chemical structure (see figure 1 .
[0064] In the present invention, since the presence of the pyridine disulfide moiety, the CPT-DSSP drug precursor can not only release the CPT in the reduction environment, but also a mercapton-disulfuridine exchange reaction, and the study found that ...
PUM
| Property | Measurement | Unit |
|---|---|---|
| size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 



